Description from Organizer: Our summit is the only event in industry with a focus this microscopic on advancements and innovations in vector development for gene therapies, returning for the fourth year in a row due to high demand and quality of insights and networking available. This summit will unite a large community of R&D and business development leaders in gene therapy to advance novel delivery platforms into the clinic. We already have over 90 biopharma, service provider, and academic pioneers attending who will sharing key insights and developments surrounding viral gene therapy vectors. Companies already represented at the summit will include Eli Lilly & Co., AskBio, GenixCure, Modalis, and Alexion Pharmaceuticals with more to be announced.